Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06176599Not ApplicableUnknown

Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis

Role: lead

NCT03009279Unknown

Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)

Role: lead

NCT03006289Unknown

Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer

Role: lead

NCT01703637Not ApplicableUnknown

Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin

Role: lead

All 4 trials loaded